BIOMAT Database Logo BIOMAT Database Logo

Role of prostaglandins and nitric oxide in gastrointestinal hyperemia of diabetic rats. 1996

E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Gastroenterology Department, Hospital Clínic, University of Barcelona, Spain.

The aim of the study was to characterize the gastric and mesenteric vascular changes induced by diabetes and the implication of endothelial [nitric oxide (NO) and prostaglandins] and humoral (glucagon) factors in such changes. Diabetes was induced in rats by a single streptozotocin injection. Four weeks later, gastric mucosa, left gastric artery, and superior mesenteric artery blood flows were measured using hydrogen gas clearance and perivascular ultrasonic flowmeter techniques, respectively, in anesthetized and fasted diabetic and control rats. Blood pressure, hematocrit, blood volume, and blood viscosity were also measured. Left gastric (41 +/- 6 vs. 25 +/- 4 ml.min-1.100 g-1) and superior mesenteric artery blood flows (83 +/- 8 vs. 65 +/- 4 ml.min-1.100 g-1) were significantly higher in diabetic than in control rats. The increased blood flow in the left gastric artery was distributed to a hypertrophic mucosa in diabetic rats; therefore, the blood flow per 100 g tissue in the gastric mucosa was not significantly different in diabetic compared with control rats. Pretreatment with indomethacin reduced both increase gastric and mesenteric flows of the diabetic rats to the same levels as in control rats. NG-nitro-L-arginine methyl ester decreased gastric blood flow in a dose-dependent manner and to a similar extent in diabetic and control rats. In contrast, an increased sensitivity to the higher doses of the NO inhibitor was observed in the mesenteric vascular bed of diabetic rats. Glucagon reduction achieved by somatostatin infusion did not influence either gastric or mesenteric blood flow in diabetic rats. In summary, the present study revealed an increase in gastric and mesenteric arterial blood flows in streptozotocin-induced diabetic rats. The gastrointestinal hyperemia seems to be due, at least in part, to the increased demand of a hypertrophic mucosa and is mediated primarily by endogenous prostaglandins. Increased vascular sensitivity to NO may also contribute to the mesenteric vasodilation.

UI MeSH Term Description Entries
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004064 Digestive System A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands (LIVER; BILIARY TRACT; PANCREAS). Ailmentary System,Alimentary System
D006940 Hyperemia The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous). Active Hyperemia,Arterial Hyperemia,Passive Hyperemia,Reactive Hyperemia,Venous Congestion,Venous Engorgement,Congestion, Venous,Engorgement, Venous,Hyperemia, Active,Hyperemia, Arterial,Hyperemia, Passive,Hyperemia, Reactive,Hyperemias,Hyperemias, Reactive,Reactive Hyperemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats.
September 1993, Hepatology (Baltimore, Md.),
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm.
October 1996, Journal of applied physiology (Bethesda, Md. : 1985),
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Role of nitric oxide in post-ischemic cerebral hyperemia in anesthetized rats.
April 1998, European journal of pharmacology,
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Role of prostaglandins and nitric oxide in gastric damage induced by metamizol in rats.
August 2002, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Role of endothelium-derived nitric oxide in myocardial reactive hyperemia.
July 1992, The American journal of physiology,
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Role of nitric oxide in PGF2 alpha-induced ocular hyperemia.
October 1994, Experimental eye research,
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
April 1996, Cardiovascular research,
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.
August 1996, Journal of hepatology,
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats.
February 1992, Hypertension (Dallas, Tex. : 1979),
E Goldin, and M Casadevall, and M Mourelle, and I Cirera, and J I Elizalde, and J Panés, and R Casamitjana, and P Guth, and J M Piqué, and J Terés
Role of nitric oxide and prostaglandins in the regulation of blood pressure in conscious rats.
June 1995, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!